Condition

Levodopa

ClinicalTrials.gov condition label

Clinical trials4

Recruiting0

Common interventions5

Lead sponsors shown4

Clinical trials

4 shown

Dopaminergic Dysfunction in Late-Life DepressionNCT04469959 · 2021-02-15

COMPLETED

Behavioural Profiling of Disease-related Cognitive and Motor Impairment in PDNCT06275633 · 2019-03-19

COMPLETED

Erythromycin in Parkinson's DiseaseNCT02005029 · 2013-04-01

COMPLETED

Open Label, Safety, Tolerability and Efficacy of AFQ056 in Parkinson's Patients With L-dopa Induced DyskinesiasNCT01173731 · 2010-10-01

COMPLETED

Common interventions

placeboDRUG2AFQ056DRUG1ErythromycinDRUG1L-DopaDRUG1LevodopaDRUG1

Leading sponsors

Novartis Pharmaceuticals1University Hospital Bispebjerg and Frederiksberg1Vanderbilt University Medical Center1Virginia Commonwealth University1

Trial status mix

COMPLETED4

Phase mix

NA2

PHASE22

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.